Trial
NCT04936230
Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Metastatic Urothelial Carcinoma
Intervention
Biospecimen Collection
Why stopped
Inadequate accrual rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-17